Evidence map›Paper›PMID 34654576›Full record

ReviewMolecular aspects of medicine2022

The peroxidatic activities of Myoglobin and Hemoglobin, their pathological consequences and possible medical interventions.

Michael T Wilson, Brandon J Reeder

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular aspects of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Spectroscopic evaluation of the interaction of myoglobin with biomedically relevant compounds.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Boosting nutritional value: the role of iron fortification in meat and meat products.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Ferroptosis as an emerging target in sickle cell disease.Current research in toxicology · 2024
    Article
  18. Article
  19. Insights into the function of cytoglobin.Biochemical Society transactions · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael T WilsonSchool of Life Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, UK. Electronic address: wilsmt@essex.ac.uk.
Brandon J ReederSchool of Life Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, UK. Electronic address: reedb@essex.ac.uk.
University of Essex · GB

Funding

Biotechnology and Biological Sciences Research Council B18662Biotechnology and Biological Sciences Research Council BB/F007663/1Biotechnology and Biological Sciences Research Council BB/L004232/1Medical Research Council MR/L01310X/1Medical Research Council MR/T025441/1Wellcome Trust
6 · The paper itself

Abstract

Under those pathological conditions in which Myoglobin and Hemoglobin escape their cellular environments and are thus separated from cellular reductive/protective systems, the inherent peroxidase activities of these proteins can be expressed. This activity leads to the formation of the highly oxidizing oxo-ferryl species. Evidence that this happens in vivo is provided by the formation of a covalent bond between the heme group and the protein and this acts as an unambiguous biomarker for the presence of the oxo ferryl form. The peroxidatic activity also leads to the oxidation of lipids, the products of which can be powerful vasoconstrictive agents (e.g. isoprostanes, neuroprostanes). Here we review the evidence that lipid oxidation occurs following rhabdomyolysis and sub-arachnoid hemorrhage and that the products formed from arachidonic acid chains of phospholipids lead, through vasoconstriction, to kidney failure and brain vasospasm. Intervention in these pathological conditions through administration of reducing agents to remove ferryl heme is discussed. Through-protein electron transfer pathways that facilitate ferryl reduction at low reductant concentration have been identified. We conclude with consideration of the therapeutic use of Hemoglobin Based Oxygen carriers and how the toxicity of these may be reduced by engineering such electron transfer pathways into hemoglobin.

Indexed as

HemoglobinsMyoglobinHemeHumansOxidation-ReductionOxygenHemeHemoglobinsMyoglobinOxygenBlood substituteFerrylHemoglobinMyoglobinPeroxidaseRhabdomyolysis

Identifiers

PMID34654576
PMCPMC8837633
OpenAlexW3207349884

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.